Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Astrid M. Hooghiemstra is active.

Publication


Featured researches published by Astrid M. Hooghiemstra.


Ageing Research Reviews | 2016

The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials.

Colin Groot; Astrid M. Hooghiemstra; P.G.H.M. Raijmakers; B.N.M. van Berckel; P. Scheltens; E.J.A. Scherder; W.M. van der Flier; Rik Ossenkoppele

Non-pharmacological therapies, such as physical activity interventions, are an appealing alternative or add-on to current pharmacological treatment of cognitive symptoms in patients with dementia. In this meta-analysis, we investigated the effect of physical activity interventions on cognitive function in dementia patients, by synthesizing data from 802 patients included in 18 randomized control trials that applied a physical activity intervention with cognitive function as an outcome measure. Post-intervention standardized mean difference (SMD) scores were computed for each study, and combined into pooled effect sizes using random effects meta-analysis. The primary analysis yielded a positive overall effect of physical activity interventions on cognitive function (SMD[95% confidence interval]=0.42[0.23;0.62], p<.01). Secondary analyses revealed that physical activity interventions were equally beneficial in patients with Alzheimers disease (AD, SMD=0.38[0.09;0.66], p<.01) and in patients with AD or a non-AD dementia diagnosis (SMD=0.47[0.14;0.80], p<.01). Combined (i.e. aerobic and non-aerobic) exercise interventions (SMD=0.59[0.32;0.86], p<.01) and aerobic-only exercise interventions (SMD=0.41[0.05;0.76], p<.05) had a positive effect on cognition, while this association was absent for non-aerobic exercise interventions (SMD=-0.10[-0.38;0.19], p=.51). Finally, we found that interventions offered at both high frequency (SMD=0.33[0.03;0.63], p<.05) and at low frequency (SMD=0.64[0.39;0.89], p<.01) had a positive effect on cognitive function. This meta-analysis suggests that physical activity interventions positively influence cognitive function in patients with dementia. This beneficial effect was independent of the clinical diagnosis and the frequency of the intervention, and was driven by interventions that included aerobic exercise.


Alzheimers & Dementia | 2017

Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease

Anna E. Leeuwis; Marije R. Benedictus; Joost P.A. Kuijer; Astrid M. Hooghiemstra; Sander C.J. Verfaillie; Teddy Koene; Philip Scheltens; Frederik Barkhof; Niels D. Prins; Wiesje M. van der Flier

We examined the association between decreased cerebral blood flow (CBF) and cognitive impairment in Alzheimers disease (AD), mild cognitive impairment (MCI), and subjective cognitive decline (SCD).


Dementia and geriatric cognitive disorders extra | 2012

Exercise and Early-Onset Alzheimer’s Disease: Theoretical Considerations

Astrid M. Hooghiemstra; Laura Eggermont; Philip Scheltens; Wiesje M. van der Flier; E.J.A. Scherder

Background/Aims: Although studies show a negative relationship between physical activity and the risk for cognitive impairment and late-onset Alzheimer’s disease, studies concerning early-onset Alzheimer’s disease (EOAD) are lacking. This review aims to justify the value of exercise interventions in EOAD by providing theoretical considerations that include neurobiological processes. Methods: A literature search on key words related to early-onset dementia, exercise, imaging, neurobiological mechanisms, and cognitive reserve was performed. Results/Conclusion: Brain regions and neurobiological processes contributing to the positive effects of exercise are affected in EOAD and, thus, provide theoretical support for exercise interventions in EOAD. Finally, we present the design of a randomized controlled trial currently being conducted in early-onset dementia patients.


Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2017

Gait Speed and Grip Strength Reflect Cognitive Impairment and Are Modestly Related to Incident Cognitive Decline in Memory Clinic Patients With Subjective Cognitive Decline and Mild Cognitive Impairment: Findings From the 4C Study

Astrid M. Hooghiemstra; Inez H.G.B. Ramakers; Nicole Sistermans; Yolande A.L. Pijnenburg; Pauline Aalten; Renske Hamel; René J. F. Melis; Frans R.J. Verhey; Marcel G. M. Olde Rikkert; Philip Scheltens; Wiesje M. van der Flier

Background Prospective studies in the general population show that slow gait speed is associated with cognitive decline and clinical progression to dementia. However, longitudinal studies in memory clinic populations are mostly lacking. We aimed to study the association between gait speed and grip strength and cognitive functioning at baseline and cognitive decline over time in memory clinic patients with subjective cognitive decline and mild cognitive impairment. Methods We included 309 patients (age 70 ± 9 years, 108 [35%] women, Mini-Mental State Examination 27 ± 3 points). Baseline gait speed was assessed over 15 feet, grip strength with a hydraulic hand dynamometer. Cognitive functioning was assessed annually with a comprehensive test battery during 3 years. Results Age- and gender-adjusted linear mixed models showed that slower gait speed was related to worse baseline attention, memory, information processing speed, and verbal fluency. Longitudinally, gait speed was related to decline in information processing speed and executive functioning. Weaker grip strength was related to worse baseline information processing speed and executive functioning but there were no longitudinal associations. Cox proportional hazards models revealed no significant associations with clinical progression. Conclusions Our findings suggest that markers of physical performance are related to current cognitive status and modestly related to cognitive decline but are seemingly not useful as an early marker of incident clinical progression.


BMC Neurology | 2012

Study protocol: EXERcise and Cognition In Sedentary adults with Early-ONset dementia (EXERCISE-ON)

Astrid M. Hooghiemstra; Laura Eggermont; Philip Scheltens; Wiesje M. van der Flier; Jet Bakker; Mathieu H.G. de Greef; Peter Koppe; E.J.A. Scherder

BackgroundAlthough the development of early-onset dementia is a radical and invalidating experience for both patient and family there are hardly any non-pharmacological studies that focus on this group of patients. One type of a non-pharmacological intervention that appears to have a beneficial effect on cognition in older persons without dementia and older persons at risk for dementia is exercise. In view of their younger age early-onset dementia patients may be well able to participate in an exercise program. The main aim of the EXERCISE-ON study is to assess whether exercise slows down the progressive course of the symptoms of dementia.Methods/DesignOne hundred and fifty patients with early-onset dementia are recruited. After completion of the baseline measurements, participants living within a 50 kilometre radius to one of the rehabilitation centres are randomly assigned to either an aerobic exercise program in a rehabilitation centre or a flexibility and relaxation program in a rehabilitation centre. Both programs are applied three times a week during 3 months. Participants living outside the 50 kilometre radius are included in a feasibility study where participants join in a daily physical activity program set at home making use of pedometers. Measurements take place at baseline (entry of the study), after three months (end of the exercise program) and after six months (follow-up). Primary outcomes are cognitive functioning; psychomotor speed and executive functioning; (instrumental) activities of daily living, and quality of life. Secondary outcomes include physical, neuropsychological, and rest-activity rhythm measures.DiscussionThe EXERCISE-ON study is the first study to offer exercise programs to patients with early-onset dementia. We expect this study to supply evidence regarding the effects of exercise on the symptoms of early-onset dementia, influencing quality of life.Trial registrationThe present study is registered within The Netherlands National Trial Register (ref: NTR2124)


Alzheimer Disease & Associated Disorders | 2015

The rest-activity rhythm and physical activity in early-onset dementia.

Astrid M. Hooghiemstra; Laura Eggermont; P. Scheltens; W.M. van der Flier; E.J.A. Scherder

Background:A substantial part of elderly persons with dementia show rest-activity rhythm disturbances. The rest-activity rhythm is important to study in people with early-onset dementia (EOD) for rest-activity rhythm disturbances are predictive of institutionalization, and caregivers of young patients suffer from high distress. Objective:The aim of this study was to study (1) whether EOD patients have more rest-activity rhythm disturbances compared with cognitively intact adults; and (2) which factors contribute to a disturbed rhythm. Methods:We included 61 patients with EOD [mean age 61.9 (4.9) y, 41 (67%) men] and 68 cognitively intact adults [mean age 61.6 (4.5) y, 28 (41%) men]. Rest-activity rhythm was assessed by actigraphy. Results:EOD patients tended to have higher intradaily variability [0.46 (0.16) and 0.39 (0.10), P=0.03]. EOD patients also lay for a longer time in bed [time in bed: 08:49 (0:51) h and 08:07 (0:47) h, P<0.001] and needed more time to fall asleep [sleep onset latency: 23 (22) min and 15 (15) min, P=0.02]. Disturbances in the rest-activity rhythm were predicted by a low level of physical activity, use of antidepressants and central nervous system neurological medications, and being male. Conclusions:EOD patients showed more variability in the rest-activity rhythm compared with cognitively intact adults. The main predictor for rest-activity rhythm disturbances was a low level of physical activity.


Cerebrovascular Diseases Extra | 2017

The Missing Link in the Pathophysiology of Vascular Cognitive Impairment: Design of the Heart-Brain Study

Astrid M. Hooghiemstra; Anne Suzanne Bertens; Anna E. Leeuwis; Esther E. Bron; Michiel L. Bots; Hans-Peter Brunner-La Rocca; Anton J. M. de Craen; Rob J. van der Geest; Jacoba P. Greving; L. Jaap Kappelle; Wiro J. Niessen; Robert J. van Oostenbrugge; Matthias J.P. van Osch; Albert de Roos; Albert C. van Rossum; Geert Jan Biessels; Mark A. van Buchem; Mat J.A.P. Daemen; Wiesje M. van der Flier

Background: Hemodynamic balance in the heart-brain axis is increasingly recognized as a crucial factor in maintaining functional and structural integrity of the brain and thereby cognitive functioning. Patients with heart failure (HF), carotid occlusive disease (COD), and vascular cognitive impairment (VCI) present themselves with complaints attributed to specific parts of the heart-brain axis, but hemodynamic changes often go beyond the part of the axis for which they primarily seek medical advice. The Heart-Brain Study hypothesizes that the hemodynamic status of the heart and the brain is an important but underestimated cause of VCI. We investigate this by studying to what extent hemodynamic changes contribute to VCI and what the mechanisms involved are. Here, we provide an overview of the design and protocol. Methods: The Heart-Brain Study is a multicenter cohort study with a follow-up measurement after 2 years among 645 participants (175 VCI, 175 COD, 175 HF, and 120 controls). Enrollment criteria are the following: 1 of the 3 diseases diagnosed according to current guidelines, age ≥50 years, no magnetic resonance contraindications, ability to undergo cognitive testing, and independence in daily life. A core clinical dataset is collected including sociodemographic factors, cardiovascular risk factors, detailed neurologic, cardiac, and medical history, medication, and a physical examination. In addition, we perform standardized neuropsychological testing, cardiac, vascular and brain MRI, and blood sampling. In subsets of participants we assess Alzheimer biomarkers in cerebrospinal fluid, and assess echocardiography and 24-hour blood pressure monitoring. Follow-up measurements after 2 years include neuropsychological testing, brain MRI, and blood samples for all participants. We use centralized state-of-the-art storage platforms for clinical and imaging data. Imaging data are processed centrally with automated standardized pipelines. Results and Conclusions: The Heart-Brain Study investigates relationships between (cardio-)vascular factors, the hemodynamic status of the heart and the brain, and cognitive impairment. By studying the complete heart-brain axis in patient groups that represent components of this axis, we have the opportunity to assess a combination of clinical and subclinical manifestations of disorders of the heart, vascular system and brain, with hemodynamic status as a possible binding factor.


Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2018

Microbleeds are associated with depressive symptoms in Alzheimer's disease

Anna E. Leeuwis; Niels D. Prins; Astrid M. Hooghiemstra; Marije R. Benedictus; Philip Scheltens; Frederik Barkhof; Wiesje M. van der Flier

Co‐occurrence of cerebrovascular disease and depression led to the “vascular depression hypothesis”. White matter hyperintensities (WMHs) have been associated with depressive symptoms in population‐based studies. We studied the association between small vessel disease and depressive symptoms in a memory clinic population.


Alzheimers & Dementia | 2018

IMPACT OF WHITE MATTER HYPERINTENSITY LOCATION ON DEPRESSIVE SYMPTOMS IN MEMORY CLINIC PATIENTS: A LESION-SYMPTOM MAPPING STUDY

Anna E. Leeuwis; Nick A. Weaver; J. Matthijs Biesbroek; Hugo J. Kuijf; Astrid M. Hooghiemstra; Niels D. Prins; Philip Scheltens; Frederik Barkhof; Wiesje M. van der Flier; Geert Jan Biessels

Background We investigated the association between white matter hyperintensity location and depressive symptoms in a memoryclinic population using lesion–symptom mapping. Methods We included 680 patients with vascular brain injury from the TRACE-VCI cohort (mean age ± standard deviation: 67 ± 8 years; 52% female): 168 patients with subjective cognitive decline, 164 with mild cognitive impairment and 348 with dementia. We assessed depressive symptoms using the Geriatric Depression Scale. We applied assumptionfree voxel-based lesion–symptom mapping, adjusted for age, sex, total white matter hyperintensity volume and multiple testing. Next, we applied exploratory region-of-interest linear regression analyses of major white matter tracts, with additional adjustment for diagnosis. Results Voxel-based lesion–symptom mapping identified voxel clusters related to the Geriatric Depression Scale in the left corticospinal tract. Region-of-interest analyses showed no relation between white matter hyperintensity volume and the Geriatric Depression Scale, but revealed an interaction with diagnosis in the forceps minor, where larger regional white matter hyperintensity volume was associated with more depressive symptoms in subjective cognitive decline (β = 0.26, p < 0.05), but not in mild cognitive impairment or dementia. Limitations We observed a lack of convergence of findings between voxel-based lesion–symptom mapping and region-of-interest analyses, which may have been due to small effect sizes and limited lesion coverage despite the large sample size. This warrants replication of our findings and further investigation in other cohorts. Conclusion This lesion–symptom mapping study in depressive symptoms indicates the corticospinal tract and forceps minor as strategic tracts in which white matter hyperintensity is associated with depressive symptoms in memory-clinic patients with vascular brain injury. The impact of white matter hyperintensity on depressive symptoms is modest, but it appears to depend on the location of white matter hyperintensity and disease severity.


Alzheimers & Dementia | 2018

PHYSICAL PERFORMANCE IN RELATION TO COGNITIVE FUNCTIONING IN PATIENTS WITH DISORDERS ALONG THE HEART-BRAIN AXIS

Astrid M. Hooghiemstra; Anna E. Leeuwis; Leonie Franken; Hans-Peter H.P. Brunner-La Rocca; Jaap Kappelle; Robert J. van Oostenbrugge; Albert C. van Rossum; Geert Jan Biessels; Wiesje M. van der Flier

At baseline, conscientiousness and neuroticism were correlated with CSF tau and ptau suggesting that personality tracks disease progression. Importantly, panel analyses indicate that changes in biomarkers occur first which lead to changes in self-assessed personality. Thus, accumulation of AD biomarkers induces changes in personality as opposed to personality traits predisposing an individual to developing pathology in DIAN.

Collaboration


Dive into the Astrid M. Hooghiemstra's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Philip Scheltens

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna E. Leeuwis

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frederik Barkhof

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Niels D. Prins

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Albert C. van Rossum

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Anne Suzanne Bertens

Leiden University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge